AMAmir Molaei

Amir Molaei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amir Molaei has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of intraperitoneal irrigation with ketamine in comparison with lidocaine on pain following laparoscopic cholecystectomy; a randomized triple-blinded clinical trial

    by Shahrzad Izadi, Saeideh Ataei, Raheb Ghorbani, Amir Molaei, Hamid Reza Hemmati

    Introduction: The most common complaint in patients undergoing laparoscopic cholecystectomy is pain, especially in the abdomen, back, and shoulder regions. Relieving of pain after laparoscopic cholecystectomy is one of the most important concerns in postoperative care. Objectives: In this study, we aimed to determine the effect of intraperitoneal Ketamine, lidocaine, and normal saline irrigation in patients undergoing laparoscopic cholecystectomy. Patients and Methods: In a randomized, triple-blinded clinical trial, 66 patients were equally assigned into three groups, and intraperitoneal irrigation was done in the first group with lidocaine+ normal saline, the second group with ketamine + normal saline, and the third group with normal saline alone. The intensity and duration of the patient’s pain in the abdomen and shoulder area, as well as the need for analgesics at intervals of 6, 12, 18, and 24 hours during the post-surgery period, were evaluated using the standard visual analogue scale (VAS) pain measurement criterion. Results: There were no significant differences between the three groups in terms of disease history, age and surgery duration, smoking, and gender. The overall intensity of shoulder pain was not different in the three groups (P=0.141, F=2.02). The overall amount of abdominal pain was not different in the three groups. (P=.078, F=2.663). Patients in whom intraperitoneal irritation was done by normal saline experienced less abdominal pain (regardless of time) than the other two groups. Conclusion: Adding ketamine or lidocaine to normal saline for intraperitoneal irrigation has no any greater effect than normal saline alone in reducing pain, duration, and frequency of need for analgesics after surgery. With due attention to the relatively better effect of normal saline and lower cost and complications, it is recommended to irrigate the surgical bed, superior surface of the liver, and under the right hemi diaphragm with normal saline. Trial registration: The trial protocol was approved in the Iranian registry of clinical trials (#IRCT 20151020024625N6; https://irct.behdasht.gov.ir/trial/29644, ethical code; IR.SEMUMS.REC.1395.94).

  • Post-cholecystectomy syndrome in patients undergoing laparoscopic cholecystectomy

    by Roya Ataei, Hamid Reza Hemmati, Shahrzad Izadi, Majid Mirmohammadkhani, Amir Molaei

    Introduction: Cholecystectomy is the gold standard for surgical treatment of cholelithiasis, biliary pain, and other gallbladder disorders, with a recovery rate of more than 90%. However, some patients suffer from post-cholecystectomy syndrome, which is the recurrence of symptoms. Objectives: We aimed to assess the prevalence of symptoms in patients before and after laparoscopic cholecystectomy surgery to determine the prevalence of post-cholecystectomy syndrome. Patients and Methods: In a cross-sectional study, 55 patients who underwent laparoscopic cholecystectomy enrolled in the study. Clinical data were recorded and patients followed up after the surgery. The symptoms and signs were recorded during hospitalization before surgery and one week and one month after surgery. Descriptive statistical methods were used for data analysis. Results: Abdominal pain was the most common preoperative complaint in 52 cases (94.5%), followed by fat intolerance in 38 cases (69%) and nausea and vomiting in 27 cases (49%). Postoperative signs and symptoms include nausea and vomiting 4.5%, indigestion 5.5%, anorexia 4.5%, heartburn 6.3%, abdominal pain 9.8%, fat intolerance 9.8%, and change of bowel habits (6.3%). In 1.7% of patients, new symptoms were observed at the end of the first month. Conclusion: In our study, the incidence of post-cholecystectomy syndrome was less than 10%, and it can be said that laparoscopic cholecystectomy is an effective treatment for symptomatic gallstones and resulted in complete improvement of symptoms in most patients.

  • Open Access

    Response to treatment with Botulinum toxin-A in patients with Refractory Chronic Migraine

    by Amir Molaei, Mehara Hemmati, Shahrzad Izadi, Fatemeh Paknazar, Saeid Shakeri, Hamidreza Hemmati

    Background: Migraine is one of the common causes of headache, and refractory migraine imposes a significant eco-nomic burden; therefore, it is important to find a proper treatment method for this condition. In this study, we evaluated the response to treatment with botulinum toxin A in patients with refractory chronic mi-graine. Materials and Methods: ...


  • Open Access

    Response to Botulinum Toxin Type-A in Patients with Refractory Chronic Migraine

    by Hamidreza Hematti, Shahrzad Izadi, Amir Molaei

    Background: Due to its debilitating nature, refractory chronic migraine (RCM) is primarily associated with a poor quality of life. However, controversy remains regarding the efficacy and safety of botulinum toxin for treating RCM. Objectives: The aim of this study was to investigate the efficacy of botulinum toxin type A (BTX-A) in patients with RCM. Methods: In this retrospective cross-sectional study conducted between April 2016 and March 2021, RCM patients who were resistant to conventional therapies and received BTX-A injections were followed for 7 and 14 days after the injection. The outcome variables included the frequency, duration, and severity of migraine episodes, the need for painkillers, adverse events, and the patient's perceived improvement. Data were analyzed using SPSS. Results: In total, 52 RCM patients with a mean age of 31.84 years participated, of whom 69.2% were female. The frequency of migraine episodes decreased from a baseline of 9.84 to 3.94 and 1.25 at 7 and 14 days after injection, respectively (P < 0.001). The duration of migraine episodes dropped from 3 hours at baseline to 1.74 and 1.17 hours at 7 and 14 days post-BTX-A injection, respectively (P < 0.001). The severity of migraines alleviated from 8.07 at baseline to 6.48 and 3.38 at the respective follow-up times (P < 0.001). The need for painkillers also decreased at follow-ups (P < 0.001). Males achieved better treatment outcomes regarding the frequency of migraine episodes and the need for medications compared to females following BTX-A treatment (P < 0.05). Frontotemporal and frontotemporal-occipital headache distributions showed fewer migraine episodes, shorter duration, less severity, and lower need for painkiller consumption compared to other migraine types (P < 0.05). The most common adverse event was localized pain (42.3%), followed by itching (25.0%). A considerable number of patients felt improvement. Conclusions: According to our findings, BTX-A is a safe and well-tolerated treatment for patients with RCM. Validation of these results requires adequately precise studies investigating the effect of BTX-A in detail.

  • Open Access

    Effect of Botulinum Toxin Type-A on Improvement of Muscle Function of Lower Limb in Children with Spastic Cerebral Palsy

    by Hamidreza Hematti, Shahrzad Izadi, Amir Molaei

    Background: Spasticity significantly contributes to the functional and postural impairments in children with cerebral palsy (CP), leading to limitations in daily independence, participation, and quality of life. Botulinum Toxin-A (BTX-A) is recognized as an effective treatment for improving outcomes related to spasticity in individuals with CP. Objectives: This study aimed to evaluate the impact of BTX-A treatment on lower limb muscle function in children with spastic CP who were unable to complete physiotherapy sessions due to muscle spasms. Methods: This cross-sectional study reviewed the medical records of 24 children with CP (14 boys, 10 girls; average age: 4.50 ± 2.70 years) who had received BTX-A injections. We recorded demographic characteristics, types of muscle dysfunction, and the number of muscles involved. BTX-A injections were administered at a dosage of 5 units/kg across multiple sites. The severity of spasticity (measured using the Ashworth scale) and motor performance (assessed by the ability to walk and stand) were evaluated 30 days after the BTX-A injection. Satisfaction levels of surgeons, physiotherapists, and parents, along with final functional outcomes, were also gathered. Data analysis was performed using SPSS. Results: The most common movement disorders observed were equinus, knee flexion, and adduction. The median score on the Ashworth scale significantly decreased (P < 0.001) following BTX-A injection. There was a notable improvement in walking and standing performance (P < 0.05), particularly among boys aged 3 years or younger (P < 0.05). Most cases showed satisfactory outcomes 30 days after BTX-A injection. Significant enhancements in the functional outcomes of children with CP were noted after a 30-day follow-up, with no significant differences related to gender, age, or the muscles involved (P > 0.05). Conclusions: The findings suggest a substantial reduction in spasticity and enhancement of functional outcomes in children with cerebral palsy after BTX-A injections. This improvement was especially evident in boys and younger children with fewer muscles involved, accompanied by notably satisfactory outcomes.


  • Open Access

    Evaluation of gallbladder microorganisms in patients undergoing cholecystectomy and its relationship with clinical and laboratory parameters

    by Hamid Reza Hemmati, Parisadat Parian, Amir Molaei, Shahrzad Izadi, Majid Mirmohammadkhani, Setareh Soltani

    Introduction: Acute cholecystitis is one of the most common gallbladder diseases. Surgical operation is still the main treatment of biliary diseases, but there may be required a period of stabilization in the hospital before cholecystectomy. Infected bile in different studies has been reported from 50% to 75%. Therefore, identification of microbial mass followed by antibiotic treatment for this disease is important. Objectives: In this study, bacterial spectrum in patients undergoing cholecystectomy was evaluated based on clinical symptoms and laboratory parameters. Patients and Methods: In this prospective cross-sectional study, all patients requiring cholecystectomy were enrolled in the study. In the study, the data on age, gender, clinical signs of all patients and laboratory results and biliary liquid experiments were collected. Results: Fourteen cases including 13 cases of E. coli and a Staphylococcus strain had positive cultures. No significant correlation was detected between gender, fever, vomiting, tenderness right upper quadrant (RUQ), anorexia, jaundice, age group and microbial growth (P>0.05). Moreover, no significant correlation between laboratory parameters such as white blood cell (WBC), total bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase, amylase and microbial growth was seen (P>0.05). Conclusion: Bile culture was positive in 14% of patients undergoing cholecystectomy and E. coli was the predominant microorganism. Frequency of positive culture is low and has no relationship with demographic, clinical and laboratory factors and could not have a significant effect on the occurrence of postoperative complications; therefore, it seems that the administration of antibiotics before surgery is not necessary.


  • Open Access

    Comparison of the Results of Simultaneous Surfactant Administration and Nasal Continuous Positive Airway Pressure (INSURE) and Non-administration of Surfactant for the Treatment of Infants with Respiratory Distress Syndrome

    by Shamsollah Noripour, Amir Molaei, Razieh Bandari, Alireza Emadi, Seyd Majid Farokhi Far, Mohammad Forozeshfard

    Background: Various strategies have been suggested for the treatment of neonatal respiratory distress syndrome (NRDS). Objectives: Nowadays, most of the high-risk pregnancies are successfully ended although they normally result in the delivery of premature and preterm neonates. The rate of NRDS increases in these neonates, which consequently demands for more interventions to save them. Methods: This was a case-control study in which, 52 neonates of 27 - 32 weeks’ gestation and birth weight 1000 - 3000 g were treated with Curosurf (a natural surfactant) and NCPAP (Nasal continuous positive airway pressure) as the case group. The control group consisted of 52 matched neonates untreated with surfactant and NCPAP. Results: Studying 6 common NRDS-induced complications (pneumothorax, pulmonary hemorrhage, chronic lung disease, intra-ventricular hemorrhage, sepsis and patent ductus arteriosus) showed that there were no significant differences between the case and control groups (P > 0.05). Also, there were no significant differences in mortality and ventilator usage rates and duration of hospitalization (P > 0.05). In total, 9 neonates in the case group (17%) and 16 in the control group (30%) died consequently. Conclusions: The results showed that surfactant therapy had no significant effect on mortality and ventilator usage rates, duration of hospitalization, and NRDS-induced complications. Keywords: Surfactant; Neonate Respiratory Distress Syndrome; Mortality